Eli Lilly and Company (LLY) Stock Forecast
US · Healthcare
Current price
$1,127.69
Market cap
$1.01T
Mean price target
$1,222.62
Implied upside
8.4%
Key takeaways
- Analysts rate Eli Lilly and Company a “Buy”, with a mean price target of $1,222.62 — about 8.4% upside from the current $1,127.69, based on 29 analysts.
- LLY is trading near its 52-week high, at 90% of the $623.78–$1,182.73 band.
Analyst consensus
| Consensus rating | Buy |
|---|---|
| Number of analysts | 29 |
| Mean target | $1,222.62 |
| High target | $1,500.00 |
| Low target | $850.00 |
| Rating split (SB / B / H / S / SS) | 6 / 18 / 6 / 1 / 0 |
Price & trading
| Current price | $1,127.69 |
|---|---|
| Previous close | $1,117.26 |
| 52-week high | $1,182.73 |
| 52-week low | $623.78 |
| 50-day average | $1,021.13 |
| Beta | 0.52 |
See the full LLY breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current Eli Lilly and Company (LLY) share price?
- Eli Lilly and Company last traded at $1,127.69 with a market capitalisation of about $1,005.6B.
- What is the analyst price target for LLY?
- The mean analyst price target for Eli Lilly and Company is $1,222.62, roughly 8.4% above the latest price. The current consensus rating is “Buy”.
- Where can I see Eli Lilly and Company's full financial metrics?
- Luminoso tracks LLY's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.